Clinical trial
Study of Dexmedetomidine for the Reversal of Cocaine's Effects on Myocardial Perfusion
NCT01927640 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Dexmedetomidine for the Reversal of Cocaine's Effects on Myocardial Perfusion
- Lead sponsor
- Cedars-Sinai Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 1, 2013
- Completion date
- January 15, 2014
- Enrollment
- 115 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.